Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJpmorgan Clav Regulatory News (JCH)

Share Price Information for Jpmorgan Clav (JCH)

Share Price is delayed by 15 minutes
Get Live Data
896.00    2.00 (0.22%)
Bid:
894.00
Ask:
900.00
Spread: 6.00 (0.671%)
Market Cap: £487.52m
JCH Live PriceLast checked at - London Stock Exchange

Intraday Jpmorgan Clav Share Chart

Dividend Declaration

15 Jul 2025 15:31

RNS Number : 1716R
JPMorgan Claverhouse IT PLC
15 July 2025
 

 

 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

JPMORGAN CLAVERHOUSE INVESTMENT TRUST PLC

(the 'Company')

 

Second quarterly interim dividend

 

 

Legal Entity Identifier: 549300NFZYYFSCD52W53

Information disclosed in accordance with DTR 6.1.13

 

 

The Directors have declared that a second quarterly interim dividend of 8.40 pence per share for the year ending 31st December 2025 will be paid on 1st September 2025 to shareholders on the register at the close of business on 25th July 2025. The ex-dividend date will be 24th July 2025.

 

As announced in the Annual Report, the Board intends to raise the first three quarterly interim dividends in 2025 to 8.40p per share, from 8.25p per share in the previous financial year, subject to any unforeseen factors and the financial position and performance of the Company at the relevant time.

 

The Company has increased its total annual dividend for 52 consecutive years and the Board's dividend policy remains to seek to increase the dividend each year and, taking a run of years together, to increase dividends at a rate close to, or above, the rate of inflation.

 

The Company offers the option for shareholders to invest their dividend in a Dividend Reinvestment Plan ('DRIP'), which is managed by the Company's registrar. For details on the DRIP, please contact the Company's Registrar, Computershare Investor Services PLC.

 

The key dates relating to this dividend are given below:

 

Ex-dividend date

24th July 2025

Record date

25th July 2025

Last date for DRIP election

8th August 2025

Payment date

1st September 2025

 

 

15th July 2025

 

For further information, please contact:

 Anmol Dhillon

 JPMorgan Funds Limited

 Company Secretary

 0800 20 40 20 (or +44 1268 44 44 70)

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVGPUUWMUPAGCA
Date   Source Headline
29th Apr 202412:01 pmRNSGearing Announcement
29th Apr 202411:04 amRNSNet Asset Value(s)
26th Apr 202410:47 amRNSNet Asset Value(s)
25th Apr 20245:03 pmRNSTransaction in Own Shares
25th Apr 202410:08 amRNSNet Asset Value(s)
24th Apr 202410:19 amRNSNet Asset Value(s)
23rd Apr 202410:31 amRNSNet Asset Value(s)
22nd Apr 202411:20 amRNSGearing announcement
22nd Apr 202410:48 amRNSNet Asset Value(s)
19th Apr 202410:26 amRNSNet Asset Value(s)
18th Apr 202410:52 amRNSNet Asset Value(s)
17th Apr 202410:43 amRNSNet Asset Value(s)
17th Apr 20247:00 amRNSDividend Declaration
16th Apr 202410:30 amRNSNet Asset Value(s)
15th Apr 20244:48 pmRNSTransaction in Own Shares
15th Apr 202411:39 amRNSGearing Anouncement
15th Apr 202410:33 amRNSNet Asset Value(s)
12th Apr 202410:59 amRNSNet Asset Value(s)
11th Apr 20243:24 pmRNSTen Largest Investments
11th Apr 202410:46 amRNSNet Asset Value(s)
10th Apr 202411:49 amRNSNet Asset Value(s)
9th Apr 202410:35 amRNSNet Asset Value(s)
8th Apr 20245:09 pmRNSTransaction in Own Shares
8th Apr 202411:56 amRNSGearing Announcement
8th Apr 202410:31 amRNSNet Asset Value(s)
5th Apr 202410:40 amRNSNet Asset Value(s)
4th Apr 20244:57 pmRNSTransaction in Own Shares
4th Apr 202410:40 amRNSNet Asset Value(s)
3rd Apr 20245:03 pmRNSTransaction in Own Shares
3rd Apr 202411:36 amRNSNet Asset Value(s)
2nd Apr 20242:45 pmRNSGearing Announcement
2nd Apr 20241:40 pmRNSNet Asset Value(s)
2nd Apr 202411:28 amRNSTotal Voting Rights
28th Mar 202410:25 amRNSNet Asset Value(s)
27th Mar 20245:44 pmRNSTransaction in Own Shares
27th Mar 202410:53 amRNSNet Asset Value(s)
26th Mar 20245:33 pmRNSTransaction in Own Shares
26th Mar 202410:43 amRNSNet Asset Value(s)
25th Mar 202412:37 pmRNSGearing Announcement
25th Mar 202411:02 amRNSNet Asset Value(s)
22nd Mar 20245:11 pmRNSTransaction in Own Shares
22nd Mar 202411:10 amRNSNet Asset Value(s)
21st Mar 202410:42 amRNSNet Asset Value(s)
21st Mar 20247:00 amRNSFINAL RESULTS FOR YEAR TO 31 DEC 2023
20th Mar 202410:35 amRNSNet Asset Value(s)
19th Mar 202410:27 amRNSNet Asset Value(s)
18th Mar 202411:46 amRNSGearing Announcement
18th Mar 202411:08 amRNSNet Asset Value(s)
15th Mar 202411:09 amRNSNet Asset Value(s)
14th Mar 20245:06 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.